Hone Health Secures $228M to Expand Physician-Led Longevity Care for Men and Women

HEALTH & BEAUTY

11/19/20263 min read

Hone Health

The conversation around healthcare is changing. Increasingly, consumers are shifting their focus from treating illness after it occurs to actively managing their health before problems arise. As interest in longevity, preventative medicine, and personalized care continues to grow, healthcare companies are racing to build solutions that help people better understand and optimize their long-term well-being.

One company at the center of this movement is Hone Health, which recently announced $228 million in financing to accelerate the expansion of its physician-led longevity platform. The funding will support new clinical programs, enhanced diagnostics, and AI-enabled technology designed to help physicians deliver more personalized and proactive care.

The financing round was led by MarcyPen Capital Partners, with additional participation from investors including Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition, Comma Capital, and ID Ventures.

Growing Demand for Preventative Health

Healthcare consumers today are becoming increasingly proactive about their health.

According to data cited by Hone Health, a significant number of consumers are actively seeking tools, testing, and guidance that help them understand their health risks and improve long-term outcomes. The company believes that traditional healthcare models often focus on treating symptoms after they appear rather than preventing issues before they develop.

Hone's platform is designed around a different philosophy. By combining comprehensive diagnostic testing, physician consultations, personalized treatment plans, and AI-powered insights, the company aims to help individuals make more informed decisions about their health over time.

Understanding the $228 Million Investment

While the headline financing amount totals $228 million, the investment includes multiple components.

The round consists of $28 million in equity financing as an extension of Hone's Series A round, alongside $200 million in growth financing from General Catalyst's Customer Value Fund. With this latest raise, Hone's total equity funding now stands at approximately $65 million.

The company plans to use the capital to expand its clinical offerings, invest in technology development, and broaden access to personalized longevity care.

Building a More Personalized Healthcare Experience

A key part of Hone's strategy involves creating a connected healthcare ecosystem where data plays a central role in care decisions.

The company's platform combines biomarker testing, physician-led consultations, health history, symptoms, medications, and advanced diagnostics to build individualized health plans. AI tools then help physicians interpret that information and create more personalized recommendations.

According to Saad Alam, Co-Founder and CEO of Hone Health, today's consumers are seeking deeper insights into their health metrics so they can make more informed decisions. Hone's model is intended to provide that understanding through a combination of clinical expertise and technology-powered analysis.

Expanding Into New Areas of Longevity Care

The funding will also support the development of new clinical pathways focused on a wider range of health concerns.

According to reports, Hone plans to expand offerings related to metabolic health, inflammation, immunity, and physician-supervised peptide programs. The company also intends to introduce additional diagnostic capabilities, including advanced imaging and microbiome analysis, while continuing to enhance its AI operating system.

These initiatives reflect the growing trend toward precision medicine, where treatment recommendations are increasingly tailored to an individual's biology, lifestyle, and health goals.

Growing List of Strategic Investors

The funding round attracted support from a diverse group of investors and advisors.

Hospitality entrepreneur David Grutman joined Hone as a strategic investor and advisor, while other notable investors include Nick Jonas, Joe Jonas, Kevin Jonas, Kelly Rowland, Braxton Berrios, former NBA player Josh Childress, and several prominent technology and healthcare investors.

Their participation reflects growing interest in the longevity sector as consumers increasingly prioritize preventative and personalized healthcare solutions.

The Future of Longevity Care

The longevity market has evolved rapidly in recent years, moving from a niche wellness category to a significant segment of modern healthcare. Consumers are increasingly looking for solutions that help them understand not only how long they may live, but how well they can live throughout those years.

With $228 million in new financing, Hone Health is positioning itself to play a larger role in that transformation. By combining physician-led care, advanced diagnostics, and AI-powered insights, the company is working to make personalized longevity care more accessible and actionable for men and women seeking a proactive approach to health.

Related Stories

Lotti Media © 2025-2026

Lotti MEDIA is your go-to source for multi-industry insights, innovation, and more.

Stay in the Know

Join our mailing list today.